Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

904.61 +14.50 (+1.63%)
Official Closing Price Updated: 7:00 PM EDT, Jun 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,839,808
Open 891.77
Bid (Size) 902.84 (1)
Ask (Size) 909.00 (1)
Prev. Close 890.11
Today's Range 891.50 - 909.42
52wk Range 434.34 - 909.42
Shares Outstanding N/A
Dividend Yield 0.50%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alphabet Among Stocks Hitting All-Time High Tuesday: See Which Stocks Just Came On IBD's Top Stock Screens
Google-parent Alphabet hit a fresh high at 184.03 Tuesday. Its earnings rose the past year to a 53% surge to $1.74 per share last quarter. 
Via Investor's Business Daily
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows
Novo Nordisk's Saxenda study published in JAMA Network Open reveals significant declines in bone density among patients, raising concerns for similar weight loss drugs. 
Via Benzinga

Performance

YTD
+52.75%
+52.75%
1 Month
+11.98%
+11.98%
3 Month
+16.74%
+16.74%
6 Month
+58.52%
+58.52%
1 Year
+99.80%
+99.80%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
This Is What Whales Are Betting On Eli Lilly and Co
Via Benzinga
NVO Stock: Novo Nordisk Pops as China Approves Wegovy Weight Loss Drug
Via InvestorPlace
1 Supercharged Vanguard Index Fund to Buy Before It Soars 174%, According to a Wall Street Analyst
Via The Motley Fool
Topics ETFs Stocks
Exposures US Equities
What's Going On With Eli Lilly Shares Monday?
Via Benzinga
Why ResMed Shares Are Trading Lower Monday
Via Benzinga
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely'
Via Benzinga
Exposures Product Safety
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Top 3 Sectors Poised For Growth This Summer
Via MarketBeat
Topics ETFs
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
Via InvestorPlace
Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
Via Investor's Business Daily
Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion
Via Benzinga
Exposures Product Safety
AbbVie Inc. Dividend Stock Analysis - Saturday, June 22
Via Talk Markets
MarketBeat Week in Review – 6/17 - 6/21
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
3 Biotech Stocks to Buy Now: June 2024
Via InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Via Benzinga
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
Via Talk Markets
Topics Lawsuit
Exposures Financial Legal
Pre-Market Movers - June 21, 2024
Via Talk Markets
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
Via Benzinga
Hype Busters: 3 Overvalued Stocks Ready for a Reality Check
Via InvestorPlace
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
Via Benzinga
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.